Dr Muthu Kumar T - Bannari Amman Institute of Technology

Experience Type	Organization	From	To	Total Experience
Engineering	Bannari Amman Institute of Technology, Sathyamangalam	01.04.2023
Research	Vellore Institute of Technology, Vellore	01.08.2019	14-03.2023	3 Year(s) & 7 Month(s)

Degree	Specialization	Institute	University	Year of Passing
B.Tech	Bio Technology	Adhiyamaan Engineering College	Anna University, Chennai	2017
M.Tech	Bio Technology	Kamaraj College of Engineering and Technology	Anna University, Chennai	2019
Ph.D	Bio Informatics	Vellore Institute of Technology, Vellore	Vellore Institute of Technology, Vellore	2023

S.No.	Subject Area
1	Bioinformatics
2	Machine Learning & Artificial Intelligence

Muthu Kumar, T., Shanthi, V., Ramanathan, K. ,”Sequential virtual screening collaborated with machine-learning strategies for the discovery of precise medicine against non-small cell lung cancer”. Journal of Biomolecular structure and Dynamics, 2023.

Muthukumar, T., Suriya, U., Rungrotmongkol, T., Ramanathan, K. ,”In Silico Screening of Available Drugs Targeting Non-Small Cell Lung Cancer Targets: A Drug Repurposing Approach”. Pharmaceutics, Vol.14, Issue 1, pp 59, 2022.

Muthu Kumar, T., Ramanathan, K. (2022). “Revealing the Potency of Natural Compounds as Dual Kinase Blockers by Structure-Based Modeling and Extensive MD Simulation Strategy”. Journal of Computational Biophysics and Chemistry, Vol. 21,Issue 05, pp, 515-528, 2022.

Muthu Kumar, T., Ramanathan, K. “Forecasting determinants of recurrence in lung cancer patients exploiting various machine learning models”. Journal of Biopharmaceutical Statistics, 2022.

Muthu Kumar, T., Shanthi, V., Ramanathan, K. “Computational biophysics approach towards the discovery of multi-kinase blockers for the management of MAPK pathway dysregulation”. Molecular Diversity, pp, 1-18, 2022.

Nivetha, R., Bhuvaragavan, S., Muthu Kumar, T., Ramanathan, K., & Janarthanan, S. “Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from Aegle marmelos deciphered using molecular docking analysis”. Journal of Biomolecular structure and dynamics, Vol. 40, Issue 21, pp 11070-11081, 2021.

Muthukumar, T., Ramanathan, K. (2021). “Drug repurposing combined with MM/PBSA based validation strategies towards MEK inhibitors screening.” Journal of Biomolecular structure and Dynamics, Vol. 40, Issue 22, pp 12392-12403, 2021.

Muthukumar, T., Shin, W.-H., Ramanathan, K. Exploring safe and potent bioactives for the treatment of non-small cell lung cancer. 3-Biotech, Vol. 11, Issue 5, pp 241, 2021

Muthukumar, T., Ramanathan, K. “MAPK: A promising signaling pathway in targeted therapy for the treatment of NSCLC”. Research Journal of Biotechnology, Vol. 16, Issue 7, pp,231 – 239, 2021.

Muthu Kumar, T., Rohini, K., Nivya James, S. V., & Ramanathan, K. “Discovery of potent Covid‐19 main protease inhibitors using integrated drug‐repurposing strategy.”, Biotechnology and Applied Biochemistry, Vol. 68, Issue 4, pp, 712-725, 2021.

Tamilmani, S., Muthukumar, T., Saravanan, S., Karventhan, B., Saravanan, K., Ramesh Babu, N.G., Ragunathan, G, “Biodegradation of Nicotine Obtained from Tobacco Powder using Pseudomonos aeruginosa Sp. “,International Journal of Engineering Research & Management, Vol. 4, Issue 1, pp 101-104, 2017

S.No.	Title	Author	Publication	Year / Month
1	Energy-Based Pharmacophore Hypothesis Combined with Molecular Simulation Protocol for the Screening of Bioactive Compounds from the Class of Actinobacteria. Methods in Actinobacteriology,	Thirunavukkarasu, M. K., & Karuppasamy, R.,		2022
2	Probiotic Polysaccharides as Toll-Like Receptor 4 Modulators—An In Silico Strategy Advances in Probiotics	Kumar, T. M., & Ramanathan, K.,	Academic Press	2021